Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China
· Delayed Price · Currency is CNY 19.57
+0.91 (4.88%)
Mar 10, 2026, 2:15 PM CST
SHE:002082 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 11,414 | 3,933 | 3,915 | 5,409 | 9,082 | 8,470 | Upgrade
|
| Market Cap Growth | 188.41% | 0.47% | -27.62% | -40.45% | 7.23% | 276.58% | Upgrade
|
| Enterprise Value | 12,338 | 4,899 | 4,825 | 5,870 | 9,910 | 10,091 | Upgrade
|
| Last Close Price | 18.66 | 6.43 | 6.28 | 8.51 | 14.27 | 13.02 | Upgrade
|
| PE Ratio | - | 70.94 | 79.56 | 58.00 | 54.55 | 29.73 | Upgrade
|
| Forward PE | - | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | Upgrade
|
| PS Ratio | 9.97 | 2.73 | 2.54 | 3.03 | 4.70 | 0.62 | Upgrade
|
| PB Ratio | 4.13 | 1.43 | 1.42 | 1.92 | 3.31 | 2.96 | Upgrade
|
| P/TBV Ratio | 5.46 | 1.89 | 1.85 | 2.54 | 4.53 | 4.43 | Upgrade
|
| P/FCF Ratio | - | 170.18 | - | - | - | - | Upgrade
|
| P/OCF Ratio | - | 32.72 | - | - | 411.24 | 56.09 | Upgrade
|
| EV/Sales Ratio | 10.78 | 3.39 | 3.13 | 3.29 | 5.13 | 0.74 | Upgrade
|
| EV/EBITDA Ratio | - | 28.75 | 29.42 | 17.40 | 32.48 | 18.51 | Upgrade
|
| EV/EBIT Ratio | - | 65.52 | 68.74 | 25.24 | 47.04 | 23.03 | Upgrade
|
| EV/FCF Ratio | - | 211.95 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.37 | 0.35 | 0.31 | 0.31 | 0.66 | Upgrade
|
| Debt / EBITDA Ratio | 8.01 | 5.93 | 5.84 | 2.55 | 2.76 | 3.44 | Upgrade
|
| Debt / FCF Ratio | - | 44.49 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.30 | 0.31 | 0.27 | 0.14 | -0.02 | 0.46 | Upgrade
|
| Net Debt / EBITDA Ratio | 7.48 | 5.04 | 4.57 | 1.18 | -0.23 | 2.39 | Upgrade
|
| Net Debt / FCF Ratio | -3.22 | 37.14 | -3.72 | -0.97 | 0.26 | -3.19 | Upgrade
|
| Asset Turnover | 0.32 | 0.34 | 0.36 | 0.42 | 0.39 | 2.54 | Upgrade
|
| Inventory Turnover | 3.28 | 3.61 | 3.41 | 3.13 | 1.80 | 15.14 | Upgrade
|
| Quick Ratio | 0.92 | 0.93 | 1.09 | 1.57 | 1.63 | 1.03 | Upgrade
|
| Current Ratio | 1.47 | 1.37 | 1.45 | 1.94 | 1.92 | 1.65 | Upgrade
|
| Return on Equity (ROE) | 0.37% | 1.64% | 0.94% | 2.65% | 5.75% | 10.27% | Upgrade
|
| Return on Assets (ROA) | 0.20% | 1.08% | 1.03% | 3.38% | 2.63% | 5.08% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.17% | 1.61% | 1.84% | 5.81% | 2.75% | 9.50% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.40% | 2.50% | 2.40% | 7.50% | 6.80% | 11.50% | Upgrade
|
| Earnings Yield | -1.74% | 1.41% | 1.26% | 1.72% | 1.83% | 3.36% | Upgrade
|
| FCF Yield | - | 0.59% | -5.15% | -7.52% | -2.90% | -4.82% | Upgrade
|
| Dividend Yield | - | - | 1.27% | 1.41% | - | 1.54% | Upgrade
|
| Payout Ratio | - | 163.85% | 247.98% | 47.08% | 115.10% | 59.93% | Upgrade
|
| Buyback Yield / Dilution | 21.16% | -0.15% | 1.06% | -0.82% | -1.73% | -21.45% | Upgrade
|
| Total Shareholder Return | 21.16% | -0.15% | 2.34% | 0.59% | -1.73% | -19.91% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.